These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23263825)
21. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994 [TBL] [Abstract][Full Text] [Related]
22. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421 [TBL] [Abstract][Full Text] [Related]
23. The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients. Milovanovic J; Todorovic-Rakovic N; Abu Rabi Z J BUON; 2013; 18(4):866-73. PubMed ID: 24344010 [TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma. Zhang C; Tu Z; Du S; Wang Y; Wang Q Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755 [TBL] [Abstract][Full Text] [Related]
25. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Tang D; Xu S; Zhang Q; Zhao W Med Oncol; 2012 Jun; 29(2):526-33. PubMed ID: 21519872 [TBL] [Abstract][Full Text] [Related]
26. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147. Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010 [TBL] [Abstract][Full Text] [Related]
27. Role of emmprin in endometrial cancer. Nakamura K; Kodama J; Hongo A; Hiramatsu Y BMC Cancer; 2012 May; 12():191. PubMed ID: 22640183 [TBL] [Abstract][Full Text] [Related]
28. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances. Huang L; Xu AM; Peng Q Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085 [TBL] [Abstract][Full Text] [Related]
29. CD147 expression in human gastric cancer is associated with tumor recurrence and prognosis. Chu D; Zhu S; Li J; Ji G; Wang W; Wu G; Zheng J PLoS One; 2014; 9(6):e101027. PubMed ID: 24979746 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast. Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261 [TBL] [Abstract][Full Text] [Related]
31. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]. Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600 [TBL] [Abstract][Full Text] [Related]
32. Elevated serum haptoglobin is associated with clinical outcome in triple-negative breast cancer patients. Tabassum U; Reddy O; Mukherjee G Asian Pac J Cancer Prev; 2012; 13(9):4541-4. PubMed ID: 23167376 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma. Tan H; Ye K; Wang Z; Tang H Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479 [TBL] [Abstract][Full Text] [Related]
34. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma. Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827 [TBL] [Abstract][Full Text] [Related]
35. EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer. Zhu S; Chu D; Zhang Y; Wang X; Gong L; Han X; Yao L; Lan M; Li Y; Zhang W Med Oncol; 2013 Mar; 30(1):369. PubMed ID: 23389916 [TBL] [Abstract][Full Text] [Related]
36. CD147 promotes invasion and MMP-9 expression through MEK signaling and predicts poor prognosis in hypopharyngeal squamous cell carcinoma. Suzuki S; Toyoma S; Kawasaki Y; Nanjo H; Yamada T Adv Clin Exp Med; 2021 Jan; 30(1):41-48. PubMed ID: 33529506 [TBL] [Abstract][Full Text] [Related]
37. MMP-1 expression has an independent prognostic value in breast cancer. Boström P; Söderström M; Vahlberg T; Söderström KO; Roberts PJ; Carpén O; Hirsimäki P BMC Cancer; 2011 Aug; 11():348. PubMed ID: 21835023 [TBL] [Abstract][Full Text] [Related]
38. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476 [TBL] [Abstract][Full Text] [Related]
39. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database. Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158 [TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer. Li Y; Wu T; Zhang B; Yao Y; Yin G Med Oncol; 2012 Dec; 29(5):3394-9. PubMed ID: 22752570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]